Ask Warren

Hyundai Pharmaceutical

004310 · KOSPI · ₩004310 · 현대약품

₩6,570▼ ₩110 (1.65%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩56B₩46B₩49B₩52B₩48B₩43B₩43B₩46B
Cost of sales₩35B₩27B₩29B₩31B₩28B₩25B₩26B₩27B
Gross profit₩21B₩20B₩20B₩21B₩21B₩18B₩17B₩19B
Operating income₩976M₩2.5B₩43M₩3.5B₩1.1B−₩415M−₩2B−₩408M
Net income₩792M₩420M−₩28M₩1.6B₩1.9B−₩985M−₩87M−₩1.6B
Net income to shareholders₩792M₩420M−₩28M₩1.6B₩1.9B−₩985M−₩87M−₩1.6B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩225B₩224B₩163B₩163B₩163B₩158B₩156B₩155B
Current assets₩108B₩101B₩81B₩85B₩85B₩80B₩80B₩81B
Cash and equivalents₩7.7B₩19B₩2.5B₩2.3B₩4.7B₩10B₩10B₩7.7B
Total liabilities₩97B₩89B₩81B₩83B₩85B₩81B₩77B₩72B
Current liabilities₩64B₩79B₩71B₩74B₩76B₩62B₩59B₩55B
Borrowings₩50B₩50B₩50B₩47B₩48B₩48B₩48B₩43B
Total equity₩128B₩135B₩82B₩80B₩78B₩78B₩79B₩82B
Shareholders' equity₩128B₩135B₩82B₩80B₩78B₩78B₩79B₩82B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩2.4B₩188M₩1.8B−₩1.2B−₩3B₩2.2B₩680M−₩1.6B
Capital spending₩261M₩1.4B₩1.2B₩613M₩1.5B₩1.3B₩1.2B₩5.7B
Free cash flow₩2.1B−₩1.2B₩618M−₩1.8B−₩4.5B₩936M−₩541M−₩7.3B
Dividends paid——₩0₩0——₩0₩0

Consolidated where available. Amounts in won.

Also known as: Hyundai Pharmaceutical / 현대약품 / 004310 / KRX:004310

Source: KRX statistical information